Morning Breakouts

Latest KFF Health News Stories

Valeant Tells Doctors That Their Prescriptions Won’t Be Disrupted

Morning Briefing

Valeant Pharmaceuticals sent a letter to doctors to try to reassure them after the company severed its controversial business ties with specialty pharmacy Philidor. In other marketplace news, Quest Diagnostics expands its data analytics business, AmSurg suspends acquisition talks with Team Health and Pamplona announced plans to buy MedAssets for $1.86 billion.

Election Results Likely To Impact Medicaid Expansion Debate

Morning Briefing

Kentucky’s expansion of the health insurance program for low income people has been a hot topic in the state’s governor’s race. Similarly, in Virginia, the possibility of Medicaid expansion is tied to who wins control of the state Senate. News outlets also report on state ballot initiatives in California and New York.

Merck CEO Embarks On Drug Cost Information Campaign

Morning Briefing

Merck’s Ken Frazier wants to change the perception that pharmaceutical companies charge too much for drugs. Elsewhere, the drug makers AbbVie and Sanofi buy vouchers to get their drugs to market faster, and Valeant sees its value come back to earth after pressures to explain its business practices.

Medicare Sets Final Rule To Pay Doctors For Consultations On ‘End-of-Life’ Care

Morning Briefing

The new rule did not ignite the fierce fight that a similar measure did during the health law debate. Medicare officials also turned down requests from hospitals to change their plans for a controversial rule to determine which patients are considered out-patient status, and the Wall Street Journal examines how the federal government is curbing the auditors who check those hospital decisions.

Health Law’s Third Open Enrollment Season Begins

Morning Briefing

Open enrollment for health coverage available on the healthcare.gov and state exchanges kicked off Nov. 1. Though the technology glitches and drama of the first sign-up period appear to be less likely, officials note challenges remain — namely, the reduced number of plan choices and the costs increases for some premiums.